Table 1.
Patient demographics for each phase of the pathway.
| Characteristic | Prevention and early detection cohort (n = 13,539) |
Diagnostic & initial treatment cohort (n = 10,807) | End-of-life cohort (n = 4278) | |
|---|---|---|---|---|
| Sex | Female | 6691 (49%) | 5410 (50%) | 2056 (48%) |
| Male | 6848 (51%) | 5397 (50%) | 2222 (52%) | |
| Age at diagnosis | Under 50 | 911 (7%) | 719 (7%) | 207 (5%) |
| 50–59 | 1702 (13%) | 1376 (13%) | 382 (9%) | |
| 60–69 | 3176 (23%) | 2614 (24%) | 734 (17%) | |
| 70–74 | 1959 (14%) | 1584 (15%) | 546 (13%) | |
| 75–79 | 2159 (16%) | 1751 (16%) | 721 (17%) | |
| 80–84 | 2047 (15%) | 1630 (15%) | 847 (20%) | |
| 85 + | 1585 (12%) | 1133 (10%) | 841 (20%) | |
| Charlson Comorbidity Index | Zero | 11,218 (85%) | 9332 (86%) | 3128 (76%) |
| At least one | 1912 (15%) | 1475 (14%) | 985 (24%) | |
| Missinga | 409 | 0 | 165 | |
| Year of cancer diagnosis | 2008 | 1925 (14%) | 1515 (14%) | 894 (21%) |
| 2009 | 1887 (14%) | 1483 (14%) | 878 (21%) | |
| 2010 | 1967 (15%) | 1601 (15%) | 731 (17%) | |
| 2011 | 1928 (14%) | 1531 (14%) | 677 (16%) | |
| 2012 | 1932 (14%) | 1598 (15%) | 535 (13%) | |
| 2013 | 1947 (14%) | 1553 (14%) | 403 (9%) | |
| 2014 | 1953 (14%) | 1526 (14%) | 160 (4%) | |
| Socio-economic position (quintiles) | (Most disadvantaged) 1 | 2729 (24%) | 2141 (23%) | 1105 (27%) |
| 2 | 2544 (22%) | 2011 (22%) | 933 (23%) | |
| 3 | 2267 (20%) | 1868 (20%) | 797 (20%) | |
| 4 | 2035 (18%) | 1647 (18%) | 649 (16%) | |
| (Least disadvantaged) 5 | 1924 (17%) | 1549 (17%) | 603 (15%) | |
| Missingb | 2040 | 1591 | 191 | |
| Remoteness | Major cities | 7842 (68%) | 6302 (68%) | 2749 (67%) |
| Inner regional | 2875 (25%) | 2279 (25%) | 1056 (26%) | |
| Outer regional/remote | 835 (7%) | 678 (7%) | 299 (7%) | |
| Missingb | 1987 | 1548 | 174 | |
| Registry derived AJCC summary stage | I | 2646 (20%) | 2139 (20%) | 238 (6%) |
| II | 4208 (31%) | 3884 (36%) | 714 (17%) | |
| III | 3283 (24%) | 3000 (28%) | 892 (21%) | |
| IV | 3402 (25%) | 1784 (17%) | 2434 (57%) | |
a
Patients without hospitalisations.
b
Including all patients diagnosed in 2014.